Entrada Therapeutics is a drug delivery platform leveraging its proprietary Endosomal Escape Vehicle (EEV)TM platform and creating a diverse and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to efficiently target and engage underlying drivers of diseases.
TRDA
14.95 as of 3/27/23
